PKM2 overexpression in AML is linked with poor prognosis enhancing leukemic cell survival, especially those carrying nucleophosmin (NPM1) mutations, which, although rare in MDS, are considered vital for their progression to AML [83]. The gene discussed is NPM1; the disease is myelodysplastic syndrome.